Tags: hepatitis | cure | Sovaldi | drug

FDA OKs Breakthrough Hepatitis Drug

Friday, 06 December 2013 04:49 PM

Gilead Sciences Inc. says the federal government has approved its highly anticipated hepatitis C drug that is expected to offer a faster cure to millions of people infected with the liver-destroying virus.
 
The Food and Drug Administration approved the pill Sovaldi as a daily treatment in combination with older drugs to treat the major forms of hepatitis C.

Current treatments for hepatitis C can take up to a year of therapy and only cure three out of four patients. Sovaldi is a daily pill that cures roughly 90 percent of patients in just 12 weeks, according to company studies.

The approval comes as the federal government urges baby boomers to get tested for the disease. Hepatitis C is five times more common among people born between 1945 and 1965.

© Copyright 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

   
1Like our page
2Share
Health-News
Gilead Sciences Inc.says the federal government has approved its highly anticipated hepatitis C drug that is expected to offer a faster cure to millions of people infected with the liver-destroying virus. The Food and Drug Administration approved the pill Sovaldi as a...
hepatitis,cure,Sovaldi,drug
129
2013-49-06
Friday, 06 December 2013 04:49 PM
Newsmax Media, Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved